Onozuka and collaborators (2008) demonstrated that daily administrated nobiletin (10 mg/kg, i.p.)for 4 months reduced Aβ plaque pathology and improved cognitive deficits in APP-SL 7–5 mice, a transgenic mouse model of AD [158]. Here, APP is linked to Alzheimer disease.